Property Summary

NCBI Gene PubMed Count 28
PubMed Score 21.79
PubTator Score 18.35

Knowledge Summary

Patent

No data available

TINX Plot

  Disease Sources (3)

Disease Target Count P-value
non-small cell lung cancer 2798 6.71509538980799E-15
posterior fossa group B ependymoma 1530 5.60700624490247E-13
atypical teratoid/rhabdoid tumor 1095 3.3019190567493E-10
juvenile dermatomyositis 1189 8.20910994499194E-10
ulcerative colitis 2087 4.76386372801514E-8
tuberculosis 1563 9.75215655490582E-8
medulloblastoma 1524 9.70972340007712E-7
pilocytic astrocytoma 3086 2.11423086986494E-6
malignant mesothelioma 3163 3.09063062358961E-6
ovarian cancer 8492 8.12012714285786E-6
lung adenocarcinoma 2714 9.51163894192565E-6
Pick disease 1893 1.11935752130555E-5
lung cancer 4473 3.3718761062512E-5
osteosarcoma 7933 3.57466486576548E-5
pediatric high grade glioma 2712 5.43798548518877E-5
primitive neuroectodermal tumor 3031 1.14882756893392E-4
psoriasis 6685 2.32961513334866E-4
medulloblastoma, large-cell 6234 6.67472562214188E-4
glioblastoma 5572 6.9794575274513E-4
intraductal papillary-mucinous adenoma (IPMA) 2956 7.60330936841643E-4
active Crohn's disease 918 9.6437086003649E-4
invasive ductal carcinoma 2950 0.00327271401967794
inflammatory breast cancer 404 0.0040685936900817
primary pancreatic ductal adenocarcinoma 1271 0.00719062048453952
ductal carcinoma in situ 1745 0.00734671794425006
intraductal papillary-mucinous carcinoma (IPMC) 2988 0.00809931179638039
progressive supranuclear palsy 674 0.0092193488046062
intraductal papillary-mucinous neoplasm (IPMN) 3289 0.0137089922779413
subependymal giant cell astrocytoma 2287 0.0303250778728855
Alzheimer's disease 644 0.0303401747959228
Disease Target Count Z-score Confidence
Trichinosis 7 3.084 1.5

Expression

Synonym

Accession Q8IXB1 Q17RJ6 Q3B7W8 Q4ZG06 Q53QT7 Q6UWZ6 Q86T61 Q8NC82 Q8TD87 Q96K38 Q96K44 Q96K54 Q9NSY6
Symbols JPDI
MTHr
ERdj5
PDIA19

Gene

  Ortholog (15)

Gene RIF (9)

PMID Text
25055872 ERdj5 is a member of the proteostasis network that regulates rod opsin biogenesis and supports a role for disulfide bond formation/reduction in rod opsin biogenesis and disease.
23769672 ERdj5 acts as the endoplasmic reticulum reductase, both preparing misfolded proteins for degradation and catalyzing the folding of proteins that form obligatory non-native disulfides.
23363602 ERdj5, by binding to Sel1L, triggers BiP-Cholera toxin interaction proximal to the Hrd1 complex; postulate this scenario enables the Hrd1-associated retrotranslocation machinery to capture the toxin efficiently once the toxin is released from BiP
19122239 ERdj5 decreases neuroblastoma cell survival by down-regulating the UPR, raising the possibility that this protein could be a target for anti-tumor approaches.
18653895 study found that an endoplasmic reticulum (ER) protein ERdj5 had a reductase activity, cleaved the disulfide bonds of misfolded proteins & accelerated ER-associated degradation through its physical and functional associations with EDEM & BiP
18400946 ERdj4 and ERdj5 promote turnover of misfolded SP-C and this activity is dependent on their ability to stimulate BiP ATPase activity.
14587667 The organization of the functional motifs of hMTHr suggests that the protein might be a member of a molecular chaperone family.
12446677 JPDI may have roles in folding of some proteins in the ER, chaperoning by BiP and formation of proper disulfide bonds
12411443 ERdj5 is a ubiquitous protein localized in the ER and is particularly abundant in secretory cells. Its transcription is induced during ER stress, suggesting potential roles for ERdj5 in protein folding and translocation across the ER membrane.

AA Sequence

MGVWLNKDDYIRDLKRIILCFLIVYMAILVGTDQDFYSLLGVSKTASSREIRQAFKKLALKLHPDKNPNN      1 - 70
PNAHGDFLKINRAYEVLKDEDLRKKYDKYGEKGLEDNQGGQYESWNYYRYDFGIYDDDPEIITLERREFD     71 - 140
AAVNSGELWFVNFYSPGCSHCHDLAPTWRDFAKEVDGLLRIGAVNCGDDRMLCRMKGVNSYPSLFIFRSG    141 - 210
MAPVKYHGDRSKESLVSFAMQHVRSTVTELWTGNFVNSIQTAFAAGIGWLITFCSKGGDCLTSQTRLRLS    211 - 280
GMLDGLVNVGWMDCATQDNLCKSLDITTSTTAYFPPGATLNNKEKNSILFLNSLDAKEIYLEVIHNLPDF    281 - 350
ELLSANTLEDRLAHHRWLLFFHFGKNENSNDPELKKLKTLLKNDHIQVGRFDCSSAPDICSNLYVFQPSL    351 - 420
AVFKGQGTKEYEIHHGKKILYDILAFAKESVNSHVTTLGPQNFPANDKEPWLVDFFAPWCPPCRALLPEL    421 - 490
RRASNLLYGQLKFGTLDCTVHEGLCNMYNIQAYPTTVVFNQSNIHEYEGHHSAEQILEFIEDLMNPSVVS    491 - 560
LTPTTFNELVTQRKHNEVWMVDFYSPWCHPCQVLMPEWKRMARTLTGLINVGSIDCQQYHSFCAQENVQR    561 - 630
YPEIRFFPPKSNKAYHYHSYNGWNRDAYSLRIWGLGFLPQVSTDLTPQTFSEKVLQGKNHWVIDFYAPWC    631 - 700
GPCQNFAPEFELLARMIKGKVKAGKVDCQAYAQTCQKAGIRAYPTVKFYFYERAKRNFQEEQINTRDAKA    701 - 770
IAALISEKLETLRNQGKRNKDEL                                                   771 - 793
//

Text Mined References (31)

PMID Year Title
25944712 2015 N-terminome analysis of the human mitochondrial proteome.
25416956 2014 A proteome-scale map of the human interactome network.
25055872 2014 The co-chaperone and reductase ERdj5 facilitates rod opsin biogenesis and quality control.
23769672 2013 ERdj5 is the ER reductase that catalyzes the removal of non-native disulfides and correct folding of the LDL receptor.
23363602 2013 The ERdj5-Sel1L complex facilitates cholera toxin retrotranslocation.
23192594 2013 Gene-environment interactions and obesity traits among postmenopausal African-American and Hispanic women in the Women's Health Initiative SHARe Study.
22229892 2012 Redox-dependent protein quality control in the endoplasmic reticulum: folding to degradation.
21632540 2011 Characterization of early EDEM1 protein maturation events and their functional implications.
21329881 2011 Structural basis of an ERAD pathway mediated by the ER-resident protein disulfide reductase ERdj5.
21269460 2011 Initial characterization of the human central proteome.
More...